SCHEMBL5625320

SCHEMBL5625320

Cc1cc(S(N)(=O)=O)ccc1NC(=O)COc1ccc(Cl)cc1C(=O)c1cc(F)cc(F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.51
MAPT P10636 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 1/20 0.48
LMNA P02545 1/20 0.48
SLC2A1 P11166 3/20 0.48
THRB P10828 1/20 0.46
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
POLB P06746 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
KCNH2 Q12809 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30601623 0.93 SLC2A1 (0.55) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5623912 0.93 SLC2A1 (0.55) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5623455 0.92 TP53 (0.54) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5626228 0.92 TP53 (0.50) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5627313 0.92 SLC2A1 (0.57) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5623755 0.92 SLC2A1 (0.53) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5623963 0.91 TP53 (0.53) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5627137 0.89 TP53 (0.51) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL5625793 0.89 TP53 (0.62) TP53MAPTSMN1; SMN2GAALMNA
SCHEMBL14419606 0.89 MAPT (0.49) TP53MAPTSMN1; SMN2GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7273863-B1 Benzophenones as inhibitors of reverse transcriptase SMITHKLINE BEECHAM CORPORATION (US) 2007-09-25 US claimed
EP-1710238-A1 Benzophenones as inhibitors of reverse transcriptase GLAXO GROUP LIMITED (GB) 2006-10-11 EP claimed
CN-1391565-A Benzophenones as reverse transcriptase inhibitors GLAXO GROUP LTD (GB) 2003-01-15 CN claimed
EP-1208091-A1 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE GLAXO GROUP LIMITED (GB) 2002-05-29 EP claimed
WO-2001017982-A1 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE GLAXO GROUP LIMITED (GB) 2001-03-15 WO claimed
US-7273863-B1 Benzophenones as inhibitors of reverse transcriptase SMITHKLINE BEECHAM CORPORATION (US) 2007-09-25 US disclosed
US-7273863-B1 Benzophenones as inhibitors of reverse transcriptase SMITHKLINE BEECHAM CORPORATION (US) 2007-09-25 US disclosed
EP-1710238-A1 Benzophenones as inhibitors of reverse transcriptase GLAXO GROUP LIMITED (GB) 2006-10-11 EP disclosed
CN-1391565-A Benzophenones as reverse transcriptase inhibitors GLAXO GROUP LTD (GB) 2003-01-15 CN disclosed
EP-1208091-A1 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE GLAXO GROUP LIMITED (GB) 2002-05-29 EP disclosed
WO-2001017982-A1 BENZOPHENONES AS INHIBITORS OF REVERSE TRANSCRIPTASE GLAXO GROUP LIMITED (GB) 2001-03-15 WO disclosed